Avoro Capital Advisors Reduces Its Stake in AKRO ($AKRO)

Avoro Capital Advisors has completely exited its position in AKRO.

Written by Trueearnings · Published Jun 13, 2026, 5:36 AM EDT · Updated Jun 14, 2026, 4:55 AM EDT

Key Points

Avoro Capital Advisors sold its entire stake of 3,955,555 shares in AKRO, exiting the position as of its latest 13F filing.
KEATING FINANCIAL ADVISORY SERVICES increased its AKRO holdings by 28 shares, while IFP ADVISORS and DEKABANK DEUTSCHE GIROZENTRALE sold all their shares.
Several insiders, including AKRO's COO and CTO, sold significant shares in December 2025; analysts have mixed ratings with recent downgrades to 'hold'.

Avoro Capital Advisors has sold its entire stake in AKRO, according to the latest 13F filing with the SEC on February 17, 2026. The firm divested 3,955,555 shares, reducing its holdings to zero. This move marks a complete exit from its previous position.

What Changed in Avoro Capital Advisors' AKRO Position

Avoro Capital Advisors previously held 3,955,555 shares of AKRO. The recent filing shows they have reduced their stake by 100%, exiting the position entirely. The value of the shares at the time of sale wasn't disclosed.

Other Institutional Activity in AKRO

KEATING FINANCIAL ADVISORY SERVICES grew its holdings by 28 shares, ending with 28 shares valued at zero dollars. Meanwhile, IFP ADVISORS, INC and DEKABANK DEUTSCHE GIROZENTRALE both sold all their holdings. IFP ADVISORS reduced its position by 18 shares, and DEKABANK DEUTSCHE GIROZENTRALE sold 20,000 shares, leaving both with no shares in AKRO.

Insider Buying and Selling at AKRO

On December 9, 2025, several insiders sold shares of AKRO. Jane Henderson sold 93,797 shares, while Jonathan Young, the Chief Operating Officer, sold 260,189 shares. Additionally, Scott Gangloff, the Chief Technology Officer, sold 296,100 shares. Timothy Rolph, the Chief Scientific Officer, sold 282,149 shares, and Catriona Yale, the Chief Development Officer, sold 74,800 shares. Timothy Rolph also made another sale of 406,014 shares.

Analysts Set New Price Targets

Analyst activity has been mixed for AKRO. On October 10, 2025, HC Wainwright & Co. downgraded the stock to a 'hold' rating with a price target of $54. A day earlier, Jefferies also downgraded AKRO to 'hold' with a $56 target. Canaccord Genuity followed suit on the same date with a 'hold' rating and a $54 target. Despite these downgrades, TD Cowen initiated coverage with a 'buy' rating and a $76 target on August 4, 2025. B of A Securities and Citigroup maintained their 'buy' ratings with targets of $64 and $78, respectively, earlier in 2025.

Bottom Line

Avoro Capital Advisors' decision to sell all its shares in AKRO reflects a significant shift in its investment strategy. Investors often track such moves to gauge market sentiment. It's important to note that 13F filings are backward-looking and may not represent the investor's current position. As institutional and insider activities unfold, they provide valuable insights without offering direct investment advice.